Replies to post #823426 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

Investor082,

Thanks for reposting that again, but your opinions & predictions are still just baseless rumor. 😶

LP is the largest SHAREHOLDER, so she’s not going to “pull the rug” or act against the best interests of shareholders, including herself.

LP has focused on building prospective value via NWBO’s associations with UCLA, Pittsburgh, Roswell, & King’s College. She has leveraged research funded by peer-reviewed grants & she built, developed, & acquired more assets for the company…

NWBO recently expanded its asset portfolio significantly in 2024 & 2025 with the IP licensing deal of more cell-based technology & the
acquisition of Advent.

✅ DCVax®-L
✅ DCVax®-Direct
✅ Polarized aDC1 Platform



AI Fact-Checking

All foregoing comments relate exclusively to the topic of Northwest Biotherapeutics and its stock. Statements are made in the context of public discussion and are directed solely at the content of claims, forecasts, or interpretations presented therein. Any emphasis in tone or phrasing is used solely to highlight discrepancies, inconsistencies, unsupported conclusions, or areas where additional substantiation may be appropriate or requested in furtherance of the discussion. Nothing herein is intended as commentary on any individual participant, identity, or posting alias.